Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Enliven Therapeutics (ELVN) Preferred Dividend Payments (2020)

Enliven Therapeutics has reported Preferred Dividend Payments over the past 1 years, most recently at -$42000.0 for Q3 2020.

  • Quarterly results put Preferred Dividend Payments at -$42000.0 for Q3 2020, changed N/A from a year ago — trailing twelve months through Dec 2020 was $7.9 million (changed N/A YoY), and the annual figure for FY2021 was $7.9 million, up 0.53%.
  • Preferred Dividend Payments reached -$42000.0 in Q3 2020 per ELVN's latest filing, down from $42000.0 in the prior quarter.
  • Across five years, Preferred Dividend Payments topped out at $7.9 million in Q1 2020 and bottomed at -$42000.0 in Q3 2020.